Trade Summary

Yesterday, Agarwal Arjun, serving as Senior Vice President, Finance at Oruka Therapeutics, Inc. (ORKA), sold 1,587 shares at $80.95 per share, for a total transaction value of $128,468.24. Following this transaction, Agarwal Arjun now holds 15,312 shares of ORKA.

This sale represents a 9.39% decrease in Agarwal Arjun's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 22, 2026 at 7:59 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.